## **THE HAREBELL CENTENARY FUND** 

**TRUSTEES’ REPORT AND FINANCIAL STATEMENTS** 

**YEAR ENDED 31 DECEMBER 2023** 



## **THE HAREBELL CENTENARY FUND** 

## I N D E X 

## **Year ended 31 December 2023** 

||**Page**|
|---|---|
|Trustees’ annual report|2|
|Independent examiner’s report|7|
|Statement of financial activities|8|
|Balance sheet|9|
|Notes to the financial statements|10|
|Appendix:  Investment portfolio|15|
|(not filed with the Charity Commission)||



1 



## **THE HAREBELL CENTENARY FUND** 

## T R U S T E E S ' A N N U A L R E P O R T 

## **Year ended 31 December 2023** 

The Trustees present their annual report along with the financial statements of the Charity for the year ended 31 December 2023.  The financial statements have been prepared in accordance with the accounting policies set out on pages 10 and 11 and comply with the Charity’s Trust Deed, the Charities Act 2011 and the Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Report Standard applicable in the UK and Republic of Ireland (FRS102). 

## **Structure, governance and management** 

The Harebell Centenary Fund is an unincorporated registered charity, which was created by Deed on 18 June 1991, with the initial Trust Fund of £100 cash.  The Trustees shall hold the capital and the income of the Trust Fund upon trust to apply the income and as far as may be necessary the capital for or towards such charitable purposes and to make donations to such charitable bodies or institutions at such times and in such manner as the Trustees may in their absolute discretion think fit. 

The minimum number of Trustees, as required by the governing Deed, is three.  Trustees serve an indefinite term based on their relative experience and contribution to the Charity as a whole.  In selecting new Trustees the existing Trustees’ policy is to take account of the benefits of appointing a person who through residence, occupation, employment or otherwise has special knowledge of the area of benefit or who is otherwise able, by virtue of his or her personal or professional qualifications, to make a contribution to the pursuit of the objects or the management of the Charity. 

Trustees are given a copy of the Charity’s governing document, accounts and financial information, policies and anything else that explains how it works. 

The Trustees meet on a six-monthly basis to agree the broad strategy and areas of activity for the Charity, including consideration of grant-making, investment, reserves and risk management policies and performance.  The day to day administration of grants and the processing and handling of applications prior to the consideration of the Trustees is handled by the Administrator.  All Trustees give of their time freely and no Trustee remuneration was paid in the year.  Details of Trustee expenses and related party transactions are disclosed in note 8 to the accounts.  Trustees are required to disclose all relevant interests and in accordance with the Charity’s policy withdraw from decisions where a conflict of interest arises. 

## **Risk management** 

The Trustees have considered the major risks to which the Charity is exposed and have reviewed those risks and established systems and procedures to manage those risks.  Major risks identified by the Trustees are the volatility of market values of the quoted investments held, and their short and long term performance and viability, together with the proper use of grants given by the Charity each year.  The Trustees will continue to keep the adequacy of the systems in place under review.  The Trustees considered that the greatest risk was the misuse of the funds that are held in custody by the brokers.  However, the Trustees had assessed the risk and, given the regulatory regime to which the investment managers are subject, were satisfied that the level of risk was minimal such that it was appropriate to be accepted by the Trustees. 

## **Objects, objectives and principal activities for the public benefit** 

Under the terms of the original Deed, the Trustees have discretion to pay or apply the Trust Fund or the income thereof to further the advancement of the education of the general public particularly in matters of providing funding to young persons to further their education, the promotion of neurological and neurosurgical research and the relief of sickness and suffering amongst animals and generally for such purposes or objects which are from time to time recognised as exclusively charitable according to the law of England and Wales. 

The Trustees, having regard to the public benefit guidance published by the Charity Commission in accordance with section 17 of the Charities Act 2011, consider that the purposes and activities of the charity satisfy the requirements of the public benefit test set out in section 4 of the same Act.  The Charity carries out these objects by providing grants to institutions which are also UK registered charities and whose objects comply with the Charity’s criteria. Whilst the Trustees are mindful of their own obligation to ensure that the Charity benefits the public generally, they take some assurance from the fact that the recipients of grants are themselves regulated to ensure that they operate in accordance with the guidance from the Charity Commission on public benefit. 

2 



## **THE HAREBELL CENTENARY FUND** 

T R U S T E E S ' A N N U A L R E P O R T ( C O N T I N U E D ) 

## **Year ended 31 December 2023** 

## **Objects, objectives and principal activities for the public benefit (continued)** 

The main aims of the Charity are: 

- To support charitable causes which are of particular interest to each individual Trustee together with causes which are of interest to the Trustees as a whole. 

- To provide charitable funding in accordance with the governing Trust Deed and the Objects contained within. 

- To maintain resources at a reasonable level in order to continue to provide general charitable assistance in the foreseeable future. 

The main objectives for the year are shaped by these strategic aims with a view to continuing to fund chosen general charitable causes in line with the Trust Deed. 

## **Grant-making policy** 

The current policy of the Trustees is to concentrate on making donations to charities which do not receive widespread public support with three main factors in mind: 

1. To reduce the administrative costs of the Charity in the making and monitoring of donations. 

2. To effectively increase the amount of distributable income. 

3. To be able to increase the amount of support to those causes for which the Trustees assess in the Charity’s donations provide a significant social reward. 

The Trustees have decided to make donations only to registered charities and not to individuals.  The Trustees do not respond to unsolicited applications as they prefer to support donations to charities whose work they have researched and which is in accordance with the aims and objectives of the Charity for the year.  Financial circumstances will be relevant only in determining the amount of an award. 

The Trustees request regular reports from the recipients of their donations to provide details of how the grants have been allocated and spent.  Grants are only continued where the applicant provides sufficient relevant information to the Trustees and satisfies the Trustees that continuation of funding is in the interests of the Charity. 

In order to enable the Trustees to be satisfied as to the work of the charities and the specific projects which they support the Trustees have agreed a rolling programme of visits to those charities which receive regular distributions from The Harebell Centenary Fund. 

During the course of the year the trustees have visited The Daws Hall Trust , Success After Stroke, Ferrriers Barn and the Tabor Centre. Mrs Angela Fossick, Trustee, has also been in contact with Age Well East, which supplied an elderly lady with hand rails, attended a zoom lecture from Morefields Eye Hospital, and met with several of the trustees of Talitha, at the Chelsea Flower Show, where they won a gold medal for their garden. 

## **Achievements and performance** 

The investment income for the year was £14,347 higher than last year.  The Trustees are satisfied with the level of investment income received by the Charity during the year ended 31 December 2023, which reflects the overall market conditions.  During the year the Charity made 13 grants (2022 - 20) to 13 charities (2022 - 20). 

3 



## **THE HAREBELL CENTENARY FUND** 

T R U S T E E S ' A N N U A L R E P O R T ( C O N T I N U E D ) 

## **Year ended 31 December 2023** 

## **Financial review (including reserves policy)** 

The Charity is reliant on the income from its investments.  The Charity’s investment income during the year ended 31 December 2023 comprised dividends and interest amounting to £243,830 (2022 - £229,483).  The governance costs of the Charity for the year ended 31 December 2023 were £16,012 (2022 - £21,172).  An income surplus arose after governance expenses for the year ended 31 December 2023 of £227,818 (2022 - £208,311) before income donations to charities of £109,400 (2022 - £194,800) and investment management fees of £45,465 (2022 - £48,054). 

The Trustees aim to maintain free reserves in unrestricted funds at a level which is sufficient to distribute the Trust Fund to charitable causes whilst retaining capital for the maintenance and growth of the Fund.  It is the policy of the Trustees to use the investments to generate income and whilst the capital can be spent it will be used to generate income. 

## **Future plans** 

It is the intention of the Trustees to continue to manage the investment portfolio so as to produce an investment income from which grants will be made to charitable organisations in line with the grant-making policy set out on page 3. 

## **Investment policy and performance** 

The charitable Trust Deed confers upon the Trustees wide powers of investment, in all respects, as if they were absolute owners beneficially entitled to the underlying assets.  At present the Charity’s funds comprise listed securities and cash.  Trust monies requiring investment under the Trust may be invested in the purchase of such stocks, funds, shares, securities or other investments of whatsoever nature as the Trustees shall in their absolute discretion think fit. The Trustees shall have the same full and unrestricted powers of investing and converting investments in all other respects as if they were absolutely entitled to the Trust fund beneficially. 

The Trustees monitor the performance of the investments held by the Charity in line with their short and long term aims and objectives.  The securities are looked after by an investment manager, who supplies advice on investment matters and manages the fund in line with the Trustees’ objectives.  The Trustees report that the total return from the investment portfolio for the year ended 31 December 2023 has been 16.1% (2022 – a negative return of 12.8%) compared to a CPI + 4% benchmark of 8.2%. 

Investments are shown at market value rather than book cost in accordance with the Statement of Recommended Practice:  Accounting by Charities (FRS102) (effective 1 January 2019).  In the year to 31 December 2023, the Charity made realised gains on listed investments of £100,224 (2022 - £156,850) and unrealised gains of £212,782 (2022 – unrealised losses of £1,172,733). 

The Trustees confirm that the Charity’s assets are sufficient to fulfil its obligations in respect of unrestricted funds and that all investments held by them on behalf of the Charity have been acquired in accordance with the powers available to them under the Trust Deed. 

The Trustees set 5% of period-end market value of the investment portfolio as the threshold for reporting material investments.  Holdings of greater than the threshold are acceptable only by the approval of the Trustees. 

The Trustees agree to a reserves policy of £50,000 in liquid assets. 

All cash is held on interest-bearing deposit. 

The Trustees are satisfied with the financial position of the Charity and confirm that they have adequate assets available to fulfil their obligations. 

## **The Accounts** 

The accounts comply with statutory requirements. 

4 



## **THE HAREBELL CENTENARY FUND** 

T R U S T E E S ' A N N U A L R E P O R T ( C O N T I N U E D ) 

## **Year ended 31 December 2023** 

## **Trustees’ responsibilities in relation to the financial statements** 

The Trustees are responsible for preparing the Trustees’ report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards.  The law applicable to charities in England and Wales requires the Trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charity and of the incoming resources and application of resources of the charity for that period.  In preparing these financial statements, the Trustees are required to: 

- select suitable accounting policies and then apply them consistently; 

- observe the methods and principles of the Charities SORP; 

- make judgements and accounting estimates that are reasonable and prudent; 

- state whether applicable accounting standards have been followed, subject to any departures disclosed and explained in the financial statements; and 

- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charity will continue in business. 

The Trustees are responsible for keeping accounting records which disclose with reasonable accuracy the financial position of the charity and enable them to ensure that the financial statements comply with the Charities Act 2011, the Charity (Accounts and Reports) Regulations 2008 and the provisions of the trust deed.  They are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. 

5 



THE HAREBELL CEKfENARY FUND
TRUSTEES
ANNUAL REPORT (CONTINUED)
Ye¥ ended 31 December IOIJ
Re£i5tered Charity ntvnber
I(1)3552
MrMIA¢xxx
M5 PJ Thapma
Mrs A R F055ick
Princ"pal office
[¢￿d￿l
ECIA 7BL
Administrator
Ms PJ Clwan
Indewdart Examiner
Stv¥en Wakefield ACA
22 Chwcery kne
WC2A ILS
Investswt ath?sers and b*ykvs
8 ￿ CiroJ5
EC2M 7A2
Solicitor5
BDB Rtnws LLP
One Banhok)mew Cls>se
ECIA7BL
&.￿led on the Trnstees. behalf by
MR N I A GOODBODY
24 July 2024

## **THE HAREBELL CENTENARY FUND** 

I N D E P E N D E N T E X A M I N E R ’ S R E P O R T 

## **Year ended 31 December 2023** 

## **INDEPENDENT EXAMINER’S REPORT TO THE TRUSTEES OF THE HAREBELL CENTENARY FUND** 

I report to the trustees on my examination of the accounts of the Trust for the year ended 31 December 2023. 

## **Responsibilities and basis of report** 

As the charity trustees of the Trust you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 2011 (‘the Act’). You are satisfied that an audit is not required for this year under charity law and that an independent examination is needed. 

I report in respect of my examination of the Trust’s accounts carried out under section 145 of the 2011 Act and in carrying out my examination I have followed all the applicable Directions given by the Charity Commission under section 145(5)(b) of the Act. Dixon Wilson, a firm of Chartered Accountants of which I am a partner has provided bookkeeping services to the Trust and I have applied the FRC’s Revised Ethical Standard in carrying out my examination. 

An independent examination does not involve gathering all the evidence that would be required in an audit and consequently does not cover all the matters that an auditor considers in giving their opinion on the accounts.  The planning and conduct of an audit goes beyond the limited assurance that an independent examination can provide. Consequently, I express no opinion as to whether the accounts present a ‘true and fair’ view and my report is limited to those specific matters set out in the independent examiner’s statement. 

## **Independent examiner’s statement** 

I am qualified to undertake the examination by being a qualified member of the Institute of Chartered Accountants in England and Wales. 

I have completed my examination. I confirm that no material matters have come to my attention in connection with the examination giving me cause to believe that in any material respect: 

1. accounting records were not kept in respect of the Trust as required by section 130 of the Act; or 

2. the accounts do not accord with those records; or 

3. the accounts do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a ‘true and fair view’ which is not a matter considered as part of an independent examination; or 

4. the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102). 

I have no concerns and have come across no matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached. 

STEVEN WAKEFIELD ACA Dixon Wilson 22 Chancery Lane London WC2A 1LS 

> 31 July 2024 

7 



## **THE HAREBELL CENTENARY FUND** 

S T A T E M E N T O F F I N A N C I A L A C T I V I T I E S 

## **Year ended 31 December 2023** 

|**Unrestricted**<br>**Expendable**<br>**income**<br>**endowment**<br>**Note**<br>**fund**<br>**fund**<br>**£**<br>**£**<br>**Income and endowments from:**<br>Investments:<br>Income from listed securities<br>230,820<br>-<br>Interest on cash deposits<br>13,010<br>-<br>Other investment income<br>-<br>-<br> <br> <br>**Total income and endowments**<br>243,830<br>-<br> <br> <br>**Expenditure on:**<br>Raising funds:<br>Investment management fees<br>-<br>45,465<br>Charitable activities:<br>Grants made<br>3<br>109,400<br>-<br>Governance costs<br>2<br>8,006<br>8,006<br> <br> <br>**Total expenditure**<br>117,406<br>53,471<br> <br> <br>**Net income/(expenditure) before**<br>**Investment gains and losses**<br>126,424<br>(53,471)<br>Net gains on investments<br>4<br>-<br>313,006<br>Net gains on foreign exchange<br>-<br>(75)<br> <br> <br>**Net income/(expenditure)**<br>126,424<br>259,460<br>Net movement in funds<br>126,424<br>259,460<br> <br>**Reconciliation of Funds**<br>Fund balances brought forward at 1 January 2023<br>48,726<br>7,541,786<br> <br> <br>**Fund balances carried forward at**<br>**31 December 2023**(page 9)<br>175,150<br>7,801,246<br>|**2023**<br>**Total**<br>**£**<br>230,820<br>13,010<br>-<br> <br>243,830<br> <br>45,465<br>109,400<br>16,012<br> <br>170,877<br> <br>72,953<br>313,006<br>(75)<br> <br>385,884<br>385,884<br> <br>7,590,512<br> <br>7,976,396<br>|**2022**<br>**Total**<br>**£**<br>222,663<br>6,690<br>130<br> <br>229,483<br> <br>48,054<br>194,800<br>21,172<br> <br>264,026<br> <br>(34,543)<br>(1,015,883)<br>429<br> <br>(1,049,997)<br>(1,049,997)<br> <br>8,640,509<br> <br>7,590,512<br>|
|---|---|---|



The notes on pages 10 to 14 form part of these financial statements. 

All amounts are attributable to continuing activities. 

All income from investments relates to unrestricted income funds. 

The Trust has no recognised gains and losses other than as stated above. 

8 



THE HAREBELL CENTENARY FUND
BALANCE SHEET
At 31 December 2023
2023
2022
Inve5tmellts:
oted investnRnrs at markttyd
7,81&197
7,563,245
Debtcrt
1.834
17&214
53,691
17&0
51691
Curvert Ilabl•de5
Credrtor& amounts falling t*Je vlthin ohe >tar
Net cwrent assetsl(Habllldes)
(17.849)
160.199
(26424)
27267
7.976.396
7J90.512
Totsl Charlty Fund
Unrestr•rt￿ Fund*
Unrestricted incc¥ne fijnd (page 8)
10
10
175.150
7￿1246
48726
7541,786
7.976.396
7.55ll5J2
The financHI statements pages 8 to 14 ￿re aFv0￿d by the Trustees on 24 July
their behal br.-
2024 and $i￿ed ¢)n
MR M I A GOODBODY
Truxee
The notes on page5 10 to 14 form parr dthese frmndal 5￿m￿r&

## **THE HAREBELL CENTENARY FUND** 

N O T E S T O T H E F I N A N C I A L S T A T E M E N T S 

## **Year ended 31 December 2023** 

## **1. Accounting policies** 

## **(a) Basis of preparation and assessment of going concern** 

The financial statements have been prepared in accordance with applicable accounting standards, the Statement of Recommended Practice "Accounting and reporting by Charities" in preparing their financial statements in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102) (effective 1 January 2019) and the Charities Act 2011.  The particular accounting policies adopted are described below. 

The Trust constitutes a public benefit entity as defined by FRS 102.  Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy note. 

The Trustees consider that there are no material uncertainties about the Trust’s ability to continue as a going concern. 

The financial statements are presented in Sterling which is the functional currency of the Trust rounded to the nearest £1. 

## **(b) Fund accounting policy** 

The Trust comprises of an unrestricted income fund and an expendable endowment fund.  Unrestricted funds are general funds that are available for use at the Trustees’ discretion in furtherance of the objectives of the Trust. Expendable endowment funds are capital funds that may be freely converted into spendable income as the Trustees see fit. 

All the Trust’s funds are unrestricted.  The income fund is held for distribution and the capital fund is held to facilitate the maintenance and growth of The Harebell Centenary Fund unless capital is needed for distributions should a shortfall arise in the income fund. 

## **(c) Income** 

Investment income is credited to the Income account when receivable.  Dividends are recognised where the Trustees are entitled to receive payment. Investment gains and losses includes any realised or unrealised gains or losses on the sale of investments and any gain or loss resulting from revaluing investments to market value at the end of the year. 

Funds added to the Trust are credited to the expendable endowment fund when receivable provided no restrictions have been specified by the donor. 

## **(d) Expenditure and liabilities** 

Liabilities are recognised as soon as there is a legal or constructive obligation committing the Trust to the expenditure, it is probable that settlement will be required and the amount of the obligation can be measured reliably. 

All expenditure is accounted for on an accruals basis. 

No material item of deferred income has been included in the accounts. 

The Trust has creditors which are measured at settlement amounts less any trade discounts. 

Donations are charged to the income or the capital account on the date of approval by the Trustees. 

Governance costs comprise all costs involving the public accountability of the Trust and its compliance with regulation and good practice and are inclusive of irrecoverable VAT.  These costs also include costs relating to the independent examination of the financial statements.  The costs have been split equally, based on a fair estimate of the time spent dealing with ongoing matters, between the income and capital account. 

10 



N O T E S T O T H E F I N A N C I A L S T A T E M E N T S 

## **THE HAREBELL CENTENARY FUND** 

## **Year ended 31 December 2023** 

## **(e) Assets** 

Fixed asset investments in quoted shares, traded bonds and similar investments are valued initially at cost and subsequently at fair value (their market value) at the year end. 

Debtors (including trade debtors and loans receivable) are measured on initial recognition at settlement amount after any trade discounts or amount advanced by the Trust. Subsequently, they are measured at the cash or other consideration expected to be received. 

## **(f) Taxation** 

The Trust is exempt from tax on income and gains falling within section 505 of the Taxes Act 1988 or section 252 of the Taxation of Chargeable Gains Act 1992 to the extent that these are applied to its charitable objectives. 

## **(g) Cash flow** 

The financial statements do not include a cash flow statement because the Trust, as a small reporting entity, is exempt from the requirement to prepare such a statement under FRS 102. 

## **2. Governance costs** 

|**Unrestricted Expendable**<br>**income endowment**<br>**fund**<br>**fund**<br>**£**<br>**£**<br>Administration fees<br>4,722<br>4,722<br>Accountancy fees<br>1,450<br>1,450<br>Independent examiner fees<br>500<br>500<br>VAT<br>1,334<br>1,334<br> <br> <br>8,006<br>8,006<br> <br>|**Unrestricted Expendable**<br>**Total**<br>**income endowment**<br>**2023**<br>**fund**<br>**fund**<br>**£**<br>**£**<br>**£**<br>9,444<br>7,072<br>7,072<br>2,900<br>1,250<br>1,250<br>1,000<br>500<br>500<br>2,668<br>1,764<br>1,764<br> <br>  <br>16,012<br>10,586<br>10,586<br> <br>|**Total**<br>**2022**<br>**£**<br>14,144<br>2,500<br>1,000<br>3,528<br>|
|---|---|---|
|||21,172<br>|



## **3. Grants made** 

|**Unrestricted Expendable**<br>**income endowment**<br>**fund**<br>**fund**<br>**£**<br>**£**<br>Age Well East<br>10,000<br>-<br>Alzheimer’s Research UK<br>-<br>-<br>Amber Trust<br>-<br>-<br>Ambitious About Autism<br>10,000<br>-<br>Batten Disease Family Association<br>-<br>-<br>Brain Tumour Support<br>10,000<br>-<br>Canine Partners for Independence<br>10,000<br>-<br>Carers Trust<br>-<br>-<br>Changing Faces<br>(10,000)<br>-<br>Crathie School<br>4,400<br>-<br> <br> <br>Carried forward<br>34,400<br>-|**Unrestricted Expendable**<br>**Total**<br>**income endowment**<br>**2023**<br>**fund**<br>**fund**<br>**£**<br>**£**<br>**£**<br>10,000<br>-<br>-<br>-<br>10,000<br>-<br>-<br>10,000<br>-<br>10,000<br>10,000<br>-<br>-<br>10,000<br>-<br>10,000<br>10,000<br>-<br>10,000<br>-<br>-<br>-<br>10,000<br>-<br>(10,000)<br>10,000<br>-<br>4,400<br>4,800<br>-<br> <br> <br> <br>34,400<br>74,800<br>-|**Total**<br>**2022**<br>**£**<br>-<br>10,000<br>10,000<br>10,000<br>10,000<br>10,000<br>-<br>10,000<br>10,000<br>4,800|
|---|---|---|
|||74,800|



11 



## **THE HAREBELL CENTENARY FUND** 

## N O T E S T O T H E F I N A N C I A L S T A T E M E N T S 

## **Year ended 31 December 2023** 

## **3. Grants made (continued)** 

|**Unrestricted Expendable**<br>**income endowment**<br>**fund**<br>**fund**<br>**£**<br>**£**<br>Brought forward<br>34,400<br>-<br>David Shepherd<br>Wildlife Foundation<br>10,000<br>-<br>Disabled Sailors Association<br>-<br>-<br>Ferriers Barn<br>10,000<br>-<br>Headway Essex<br>10,000<br>-<br>Helen & Douglas House Hospice<br>-<br>-<br>Omega<br>5,000<br>-<br>Parkinson’s UK<br>-<br>-<br>St Helena Hospice<br>-<br>-<br>Success After Stroke<br>10,000<br>-<br>Support Dogs<br>-<br>-<br>Talitha Arts<br>10,000<br>-<br>The Daws Hall Trust<br>10,000<br>-<br>The Macular Society<br>-<br>-<br>The Tabor Centre<br>10,000<br>-<br> <br> <br>Total<br>109,400<br>-<br>|**Unrestricted Expendable**<br>**Total**<br>**income endowment**<br>**2023**<br>**fund**<br>**fund**<br>**£**<br>**£**<br>**£**<br>34,400<br>74,800<br>-<br>10,000<br>-<br>-<br>-<br>10,000<br>-<br>10,000<br>10,000<br>-<br>10,000<br>10,000<br>-<br>-<br>10,000<br>-<br>5,000<br>-<br>-<br>-<br>10,000<br>-<br>-<br>10,000<br>-<br>10,000<br>10,000<br>-<br>-<br>10,000<br>-<br>10,000<br>10,000<br>-<br>10,000<br>10,000<br>-<br>-<br>10,000<br>-<br>10,000<br>10,000<br>-<br> <br> <br> <br>109,400<br>194,800<br>-<br> <br>|**Total**<br>**2022**<br>**£**<br>74,800<br>-<br>10,000<br>10,000<br>10,000<br>10,000<br>-<br>10,000<br>10,000<br>10,000<br>10,000<br>10,000<br>10,000<br>10,000<br>10,000<br>194,800|
|---|---|---|



All grants were made to institutions, with no restrictions attached and are to be used by the Trust to meet its general objectives. 

|**4.**<br>**Fixed asset investments**<br>**Listed investments**<br>Market value at 1 January<br>Acquisitions at cost<br>Proceeds of disposals<br> <br>Net realised and unrealised gains<br>in the year to 31 December<br> <br>Market value at 31 December<br>Cash and settlements pending, held as part of the investment portfolio<br> <br>|**2023**<br>**2022**<br>**£**<br>**£**<br>6,814,807<br>8,159,021<br>3,293,267<br>1,387,325<br>(2,789,091)<br>(1,715,656)<br>313,006<br>(1,015,883)<br> <br> <br>7,631,989<br>6,814,807<br>184,208<br>748,438<br> <br> <br>7,816,197<br>7,563,245<br> <br>|
|---|---|



12 



## **THE HAREBELL CENTENARY FUND** 

## N O T E S T O T H E F I N A N C I A L S T A T E M E N T S 

## **Year ended 31 December 2023** 

|**5.**<br>**Debtors**<br>Accrued income|**2023**<br>**£**<br>1,834<br> <br>1,834<br>|**2022**<br>**£**<br>-<br>|
|---|---|---|
|||-<br>|
||||
|**6.**<br>**Cash**<br>Cash held with investment manager – income accounts<br> <br>|**2023**<br>**£**<br>176,214<br> <br>176,214<br>|**2022**<br>**£**<br>53,691<br>|
|||53,691<br>|
||||
|**7.**<br>**Creditors: amounts falling due within one year**<br>**Other creditors and accruals**<br>Administration fees<br>Accountancy fees<br>Investment management fees|**2023**<br>**£**<br>1,409<br>4,440<br>12,000<br> <br>17,849<br>|**2022**<br>**£**<br>10,224<br>4,200<br>12,000<br>|
|||26,424<br>|



## **8. Trustees’ remuneration and expenses** 

No Trustee received remuneration during the year.  Trustee Ms P J Chapman is a partner of BDB Pitmans LLP. BDB Pitmans LLP charged net fees of £9,444 (2022 - £13,719) in respect of professional fees during the year.  The Fund owed BDB Pitmans LLP £1,408 (2022 - £1,314) at the balance sheet date.  The Trustees are authorised by the Trust Deed to pay professional charges to Trustees engaged in a professional capacity on the instructions of the other Trustees.  The Trustees have not purchased indemnity insurance. 

13 



## **THE HAREBELL CENTENARY FUND** 

N O T E S T O T H E F I N A N C I A L S T A T E M E N T S 

## **Year ended 31 December 2023** 

## **9. Employees** 

The number of employees employed by the trust in the year was nil (2022 – nil). 

|**10.**<br>**Unrestricted funds**<br>Unrestricted income fund<br>Expendable endowment fund<br> <br>|**Funds**<br>**brought**<br>**Incoming**<br>**Outgoing**<br>**forward**<br>**resources**<br>**resources**<br>**£**<br>**£**<br>**£**<br>48,726<br>243,830<br>(117,406)<br>7,541,786<br>-<br>(53,471)<br> <br> <br> <br>7,590,512<br>243,830<br>(170,877)<br> <br>|**Gains**<br>**£**<br>-<br>312,931<br> <br>312,931<br>|**Funds**<br>**carried**<br>**forward**<br>**£**<br>175,150<br>7,801,246<br> <br>7,976,396<br>|
|---|---|---|---|



|**11.**<br>**Analysis of total net assets between funds**<br>**Unrestricted**<br>**Expendable**<br>**income**<br>**endowment**<br>**fund**<br>**fund**<br>**£**<br>**£**<br>Funds as at 31 December 2023<br>are represented by:<br>Investments at market value<br>-<br>7,816,197<br>Debtors<br>1,834<br>-<br>Cash at bank<br>176,214<br>-<br>Creditors<br>(2,898)<br>(14,951)<br> <br> <br>175,150<br>7,801,246<br> <br>|**11.**<br>**Analysis of total net assets between funds**<br>**Unrestricted**<br>**Expendable**<br>**income**<br>**endowment**<br>**fund**<br>**fund**<br>**£**<br>**£**<br>Funds as at 31 December 2023<br>are represented by:<br>Investments at market value<br>-<br>7,816,197<br>Debtors<br>1,834<br>-<br>Cash at bank<br>176,214<br>-<br>Creditors<br>(2,898)<br>(14,951)<br> <br> <br>175,150<br>7,801,246<br> <br>|**11.**<br>**Analysis of total net assets between funds**<br>**Unrestricted**<br>**Expendable**<br>**income**<br>**endowment**<br>**fund**<br>**fund**<br>**£**<br>**£**<br>Funds as at 31 December 2023<br>are represented by:<br>Investments at market value<br>-<br>7,816,197<br>Debtors<br>1,834<br>-<br>Cash at bank<br>176,214<br>-<br>Creditors<br>(2,898)<br>(14,951)<br> <br> <br>175,150<br>7,801,246<br> <br>|**Total**<br>**2023**<br>**£**<br>7,816,197<br>1,834<br>176,214<br>(17,849)<br>|
|---|---|---|---|
||||7,976,396<br>|
|||||
|**12.**<br>**Financial instruments**<br>Financial assets measured at fair value through income and expenditure||**2023**<br>**£**<br>7,816,197|**2022**<br>**£**<br>7,563,245|



Financial assets measured at fair value through income and expenditure comprise fixed assets investments. 

14 



## **THE HAREBELL CENTENARY FUND** 

A   P   P   E   N   D   I   X   :       I   N   V   E   S   T   M   E   N   T       P   O   R   T   F   O   L   I   O 

## **Year ended 31 December 2023** 

|**Name**<br>**Security Type**<br>Aalberts Industries<br>SV EUR0.25 Shares<br>Accenture plc<br>New A class shares<br>Advantest Corp<br>NPV shares<br>Alibaba Group HLDG<br>USD0.000003125 Shares<br>Allkem Ltd<br>NPV Shares<br>Alphabet inc<br>USD0.001 Cls A Common Stock<br>Alphawave IP Group PLC<br>1p Ordinary Shares<br>Amada Co Ltd<br>NPV shares<br>Antofagasta Plc<br>5p Ordinary Shares<br>Ashtead Group Plc<br>10p Ordinary Shares<br>ASML Holdings NV<br>EUR0.09 Shares post split<br>Assicurazioni Generali SPA<br>6.269% Fltg Rt Sub 16/6/Perp26<br>Astrazeneca Plc<br>USD0.25 Ordinary Shares<br>Aurelius AG<br>NPV shares<br>Aviva Plc<br>32.8947368p Ordinary Shares<br>Bank Of America Corp<br>NPV Common Stock<br>Barclays Plc<br>25p Ordinary Shares<br>Bayer AG<br>NPV Shares<br>Becton Dickinson & Co<br>NPV Common Stock<br>Berkshire Hathaway Inc<br>USD0.0033 Cls B Common Stock<br>BHP Group Plc<br>NPV Ordinary Shares<br>BP Plc<br>USD0.25 Shares<br>Breedon Group Plc<br>NPV Ordinary shares<br>Breedon Group Plc<br>1p Ordinary shares<br>Brookfield Asset Management<br>Cls A Limited Voting Shs<br>Brookfield Corp<br>Cls A Limited Voting Shs<br>Brown Advisory Funds<br>US Mid Cap Growth C<br>Capital Group<br>Global High Inc Opps<br>Capri Holdings Ltd<br>NPV Common Stock<br>Citigroup Inc<br>2.75% Snr notes<br>Citigroup Inc<br>USD0.01 Common Stock<br>Clorox Co<br>USD1 Common Stock<br>Coca-cola Co<br>USD0.25 Common Stock<br>Chikara Funds<br>Japan Alpha T<br>**Carried forward**<br>15||**A**|**t 1January 2023**||**Additions**|||**Disposals**||**At 31**|**Market Value**<br>**£**<br>42,524<br> <br>-<br>68,864<br> <br>-<br>57,135<br>57,090<br>6,955<br>27,728<br>39,703<br>157,743<br>72,656<br>62,062<br>137,800<br> <br>-<br>37,993<br> <br>-<br>37,276<br>24,150<br> <br>-<br>57,354<br>69,927<br>67,172<br> <br>-<br>13,792<br>45,971<br> <br>-<br> <br>-<br>210,058<br> <br>-<br>40,944<br> <br>-<br> <br>-<br>47,845<br> <br>-<br>1,382,742<br>**December 2023**|**Net Income**<br>**£**<br>603<br>129<br>407<br>-<br>-<br>-<br>-<br>791<br>1,177<br>2,293<br>563<br>2,783<br>3,050<br>-<br>2,779<br>693<br>1,866<br>1,278<br>329<br>-<br>3,600<br>3,218<br>267<br>152<br>3,407<br>345<br>-<br>14,268<br>-<br>-<br>1,160<br>358<br>1,292<br>-|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
||**Holding**<br>-<br>186<br>645<br>900<br>10,712<br>521<br>5,400<br>3,390<br>2,794<br>2,888<br>133<br>65,000<br>1,300<br>1,278<br>8,740<br>1,537<br>24,240<br>716<br>176<br>205<br>2,600<br>14,410<br>19,053<br>-<br>952<br>3,808<br>1,434<br>6,536<br>690<br>-<br>1,092<br>221<br>1,035<br>10,801<br>193,393|**Book Value**<br>**£**<br>-<br>33,347<br>22,472<br>7,708<br>29,239<br>32,132<br>20,404<br>25,878<br>22,713<br>21,704<br>25,562<br>64,788<br>57,240<br>32,416<br>24,973<br>44,037<br>57,740<br>36,929<br>32,074<br>35,138<br>36,214<br>72,725<br>11,648<br>-<br>13,927<br>73,264<br>15,557<br>235,694<br>26,669<br>-<br>42,473<br>32,431<br>37,921<br>31,718|**Market Value**<br>**£**<br> <br>-<br> <br>41,260<br> <br>34,461<br> <br>8,268<br> <br>67,878<br> <br>38,214<br> <br>5,508<br> <br>22,085<br> <br>43,181<br> <br>136,314<br> <br>59,449<br> <br>66,502<br> <br>145,834<br> <br>20,863<br> <br>38,701<br> <br>42,319<br> <br>38,425<br> <br>30,870<br> <br>37,207<br> <br>52,643<br> <br>66,820<br> <br>68,433<br> <br>11,622<br> <br>-<br> <br>22,646<br> <br>99,484<br> <br>19,445<br> <br>212,672<br> <br>32,880<br> <br>-<br> <br>41,060<br> <br>25,782<br> <br>54,731<br> <br>-|**Quantity**<br>1,250<br> <br>-<br> <br>1,935<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>111<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>(19,053)<br>3,810<br> <br>500<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br>40,000<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br>|**Cost**<br>45,397<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>5,478<br>-<br>-<br>-<br>-<br>(11,648)<br>11,648<br>12,562<br>-<br>-<br>-<br>-<br>39,567<br>-<br>-<br>-<br>-|**Quantity**<br>**Proceeds**<br>-<br>-<br>186        38,912<br> <br>-<br>-<br>900          7,602<br> <br>1,190          7,532<br> <br>-<br>-<br> <br>-<br>-<br> <br>-<br>-<br>430          7,325<br> <br>-<br>-<br>10          5,644<br> <br>5,000          5,208<br> <br>-<br>-<br> <br>1,278        19,260<br> <br>-<br>-<br> <br>1,537        34,524<br> <br>-<br>-<br>-<br>-<br>176        35,017<br> <br>-<br>-<br> <br>-<br>-<br> <br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br> <br>3,808      102,467<br> <br>1,434        20,191<br> <br>-              135<br>690        29,545<br>-<br>-<br> <br>1,092        35,711<br>221        26,001<br> <br>-<br>-<br>10,801        61,609<br>436,683||**Profit/(Loss)**<br> <br>-<br> <br>5,565<br> <br>-<br> <br>(106)<br> <br>4,284<br> <br>-<br> <br>-<br> <br>-<br> <br>3,829<br> <br>-<br> <br>3,722<br> <br>224<br> <br>-<br> <br>(13,156)<br> <br>-<br> <br>(9,513)<br> <br>-<br> <br>-<br> <br>2,943<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>29,202<br> <br>4,634<br> <br>-<br> <br>2,876<br> <br>-<br> <br>(6,763)<br> <br>(6,430)<br> <br>-<br> <br>29,892|**Holding**<br>1,250<br>-<br>2,580<br>-<br>9,522<br>521<br>5,400<br>3,390<br>2,364<br>2,888<br>123<br>60,000<br>1,300<br>-<br>8,740<br>-<br>24,240<br>827<br>-<br>205<br>2,600<br>14,410<br> <br>-<br>3,810<br>1,452<br>-<br>-<br>6,536<br>-<br>40,000<br>-<br>-<br>1,035<br>-|**Book Value**<br>**£**<br> <br>45,397<br> <br>-<br> <br>22,472<br> <br>-<br> <br>25,991<br> <br>32,132<br> <br>20,404<br> <br>25,878<br> <br>19,217<br> <br>21,704<br> <br>23,640<br> <br>59,804<br> <br>57,240<br> <br>-<br> <br>24,973<br> <br>-<br> <br>57,740<br> <br>42,407<br> <br>-<br> <br>35,138<br> <br>36,214<br> <br>72,725<br> <br>-<br> <br>11,648<br> <br>26,489<br> <br>-<br> <br>-<br> <br>235,559<br> <br>-<br> <br>39,567<br> <br>-<br> <br>-<br> <br>37,921<br> <br>-|||
|||1,256,735|<br>1,585,557||103,004||436,683|<br>51,203||974,260||46,808|





## **THE HAREBELL CENTENARY FUND** 

A   P   P   E   N   D   I   X   :       I   N   V   E   S   T   M   E   N   T       P   O   R   T   F   O   L   I   O 

## **Year ended 31 December 2023** 

|**Name**<br>**Security Type**<br>**Brought forward**<br>Coupland Cardiff Funds<br>Japan Inc & Gth Found Inc (US$)<br>Croda International Plc<br>10.609756p Ordinary Shares<br>Daifuku Co Ltd<br>NPV Shares<br>Daikin Industries Ltd<br>NPV Shares<br>Daiseki Co Ltd<br>NPV Shares<br>Deutsche Bank AG<br>4% Fltg Rt Nt<br>Diageo Plc<br>28 101/108p Ordinary Shares<br>DSM FIRMENICH AG<br>EUR0.01 Shares<br>Elementis Plc<br>5p Ordinary Shares<br>Emerson Electric Co<br>USD0.50 Common Stock<br>Experian Plc<br>USD0.10 Ordinary Shares<br>Fair Oaks Income Fund Ltd<br>NPV Ord 2021 Shares<br>Ferrari NV<br>EUR0.01 Common Stock<br>First Quantum Minerals Ltd<br>NPV Common Stock<br>Future Plc<br>15p Ordinary Shares<br>GCP Infrastructure Inv Ltd<br>1p Ordinary Shares<br>Genus Plc<br>10p Ordinary Shares<br>Gold Bullion Securities Ltd<br>Gold Bullion Secs<br>Goldman Sachs<br>3.125% Snr MTN 25/07/2029<br>Govt of Japan<br>0.005% I/L Snr 10/03/2031<br>GSK PLC<br>31 1/4p Ordinary Shares<br>GSK PLC<br>25p Ordinary Shares<br>Haleon PLC<br>1p Ordinary Shares<br>Hewlett-Packard Corp<br>USD0.01 Common Stock<br>HITACHI LTD<br>NPV Shares<br>Howden Joinery Group Plc<br>10p Ordinary Shares<br>Hoya Corp<br>NPV Shares<br>HSBC Holdings Plc<br>5.3% Fltg Rt Nt Sub<br>HSBC Holdings Plc<br>USD0.50 Ordinary Shares<br>Informa Plc<br>0.1p Ordinary Shares<br>Ishares Plc<br>Physical Silver ETC GBP<br>ISHARES III PLC<br>S&P equal weight UCITS hgd ETF<br>JCU Corp<br>NPV Shares<br>Johnson & Johnson<br>USD1 Common Stock<br>Keyence CORP<br>NPV Shares<br>Koninklijke DSM<br>EUR1.50 Shares<br>**Carried forward**||**A**|**t 1January 2023**||**Additions**|||**Disposals**||**At 31**|**Market Value**<br>**December 2023**<br>1,382,742<br> <br>-<br>72,417<br>28,569<br>26,857<br> <br>-<br>74,447<br>79,540<br>35,714<br>22,996<br> <br>-<br>126,479<br>127,731<br>63,999<br> <br>-<br>16,300<br>64,151<br>52,080<br>179,394<br>67,641<br>32,066<br>53,077<br> <br>-<br> <br>-<br> <br>-<br>52,061<br>34,985<br>38,247<br>37,933<br>54,018<br>35,779<br>58,191<br>20,535<br>39,419<br> <br>-<br>27,652<br> <br>-<br>2,905,020|**Net Income**|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
||**Holding**<br>193,393<br>-<br>1,434<br>400<br>175<br>860<br>-<br>2,785<br>-<br>18,022<br>498<br>3,950<br>272,373<br>242<br>1,976<br>2,049<br>77,484<br>2,400<br>1,199<br>72,000<br>5,400,000<br>3,660<br>-<br>4,575<br>2,222<br>920<br>4,300<br>390<br>-<br>8,500<br>4,580<br>2,812<br>-<br>1,380<br>365<br>-<br>302<br>6,085,246|**Book Value**|**Market Value**|**Quantity**<br> <br> <br>-<br> <br>-<br> <br>1,400<br> <br>35<br> <br>250<br>75,000<br> <br>-<br>448<br> <br>-<br> <br>-<br> <br>-<br> <br>23,685<br> <br>-<br> <br>-<br> <br>-<br> <br>11,614<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br>60,000<br> <br>-<br> <br>-<br> <br>448<br>3,800<br> <br>400<br> <br>-<br>80<br> <br>(302)<br>|**Cost**|**Quantity**<br>**Proceeds**<br>436,683<br> <br>-<br>-<br> <br>-<br>-<br>-<br>-<br>-<br>-<br>1,110        22,782<br>-<br>-<br> <br>-<br>-<br>-<br>-<br> <br>-<br>-<br>498        32,693<br> <br>-<br>-<br>-<br>-<br> <br>-<br>-<br> <br>1,976        34,300<br> <br>-<br>-<br>-<br>-<br> <br>-<br>-<br> <br>-<br>-<br> <br>-<br>-<br> <br>-<br>-<br> <br>-<br>-<br> <br>-<br>-<br> <br>4,575        14,734<br> <br>2,222        24,463<br> <br>-<br>-<br> <br>-<br>-<br> <br>-<br>-<br>-<br>-<br> <br>-<br>-<br> <br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>365        45,110<br>-<br>-<br>-<br>-<br>610,765||**Profit/(Loss)**|**Holding**<br> <br>-<br>1,434<br>1,800<br>210<br>-<br>75,000<br>2,785<br>448<br>18,022<br>-<br>3,950<br>296,058<br>242<br>-<br>2,049<br>89,098<br>2,400<br>1,199<br>72,000<br>5,400,000<br>3,660<br> <br>-<br>-<br>-<br>920<br>4,300<br>390<br>60,000<br>8,500<br>4,580<br>3,260<br>3,800<br>1,780<br>-<br>80<br> <br>-|**Book Value**|||
|||1,256,735<br>-<br>43,044<br>26,731<br>21,421<br>28,383<br>-<br>26,794<br>-<br>18,000<br>31,301<br>21,353<br>146,351<br>33,098<br>38,004<br>33,335<br>89,294<br>28,972<br>127,940<br>74,205<br>36,585<br>51,504<br>-<br>11,427<br>20,279<br>25,158<br>12,488<br>27,510<br>-<br>58,698<br>22,566<br>47,122<br>-<br>33,462<br>45,094<br>-<br>24,209|<br>1,585,557<br>64,948<br> <br>94,701<br> <br>15,575<br> <br>22,272<br> <br>24,600<br> <br>-<br> <br>101,653<br> <br>-<br> <br>21,698<br> <br>39,769<br> <br>111,114<br> <br>110,951<br> <br>42,985<br> <br>34,298<br> <br>25,961<br> <br>79,034<br> <br>71,616<br> <br>168,004<br> <br>63,319<br> <br>35,252<br> <br>52,616<br> <br>-<br> <br>14,976<br> <br>29,481<br> <br>38,784<br> <br>24,149<br> <br>31,219<br> <br>-<br> <br>43,835<br> <br>28,378<br> <br>53,512<br> <br>-<br> <br>26,780<br> <br>53,602<br> <br>-<br> <br>30,626||103,004<br>-<br>-<br>9,526<br>5,013<br>6,197<br>73,029<br>-<br>37,557<br>-<br>-<br>-<br>10,175<br>-<br>-<br>-<br>8,243<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>36,911<br>-<br>-<br>8,457<br>19,729<br>8,150<br>-<br>27,025<br>(24,209)|||<br>51,203<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>(11,798)<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>1,392<br> <br>-<br> <br>-<br> <br>-<br> <br>(3,704)<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>3,307<br> <br>4,184<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>16<br> <br>-<br> <br>-||974,260<br> <br>-<br> <br>43,044<br> <br>36,257<br> <br>26,434<br> <br>-<br> <br>73,029<br> <br>26,794<br> <br>37,557<br> <br>18,000<br> <br>-<br> <br>21,353<br> <br>156,526<br> <br>33,098<br> <br>-<br> <br>33,335<br> <br>97,537<br> <br>28,972<br> <br>127,940<br> <br>74,205<br> <br>36,585<br> <br>51,504<br> <br>-<br> <br>-<br> <br>-<br> <br>25,158<br> <br>12,488<br> <br>27,510<br> <br>36,911<br> <br>58,698<br> <br>22,566<br> <br>55,579<br> <br>19,729<br> <br>41,612<br> <br>-<br> <br>27,025<br> <br>-||46,808<br>-<br>1,549<br>244<br>249<br>280<br>2,604<br>2,228<br>501<br>-<br>357<br>1,722<br>21,392<br>280<br>-<br>70<br>5,424<br>768<br>-<br>2,250<br>1<br>2,031<br>-<br>192<br>364<br>663<br>890<br>202<br>-<br>3,605<br>577<br>-<br>-<br>497<br>585<br>-<br>-|
|||2,461,063|<br>3,141,265||328,808||610,765|<br>44,600||2,223,706||96,333|





## **THE HAREBELL CENTENARY FUND** 

A   P   P   E   N   D   I   X   :       I   N   V   E   S   T   M   E   N   T       P   O   R   T   F   O   L   I   O 

## **Year ended 31 December 2023** 

|**Name**<br>**Security Type**<br>**Brought forward**<br>Lazard Fund Mgrs (Ire)<br>Gbl Listed Infra Eqty A Inc<br>Legal & General Group Plc<br>2 1/2p Ordinary Shares<br>Linde plc<br>EUR0.001 Common Shares<br>Lloyds Banking Group Plc<br>2.707% Fltg Rt Sub<br>Lloyds Banking Group Plc<br>10p Ordinary Shares<br>LVMH Moet Hennessy SA<br>EUR0.30 Shares<br>Lynas Rare Earths LTD<br>NPV Shares<br>M&G Plc<br>5p Ordinary Shares<br>Mayfair Capital Investment Management<br>Property Inc Trust for Charity<br>Mercedes-Benz Group AG<br>NPV Ordinary Shares<br>Microsoft Corp<br>USD 0.00000625 Common Stock<br>Nestle SA<br>CHF1 Shares Regd<br>Nichols Plc<br>10p Ordinary Shares<br>Nintendo Co Ltd<br>NPV Shares<br>Nordic Investment Bank<br>1.5% Snr Bond<br>Novo-Nordisk AS<br>DKK0.1 Ser B Shares<br>Novo-Nordisk AS<br>DKK0.2 Ser B Post Split<br>Palantir Technologies Inc<br>USD0.001 Cls A Common Stock<br>Paypal Holdings Inc<br>USD0.0001 Common Stock<br>Pension Insurance Corp<br>6.5% Sub 3/07/2024<br>PGH Capital Ltd<br>6.625% Gtd Sub Nts 18/12/2025<br>Pola Orbis<br>NPV Shares<br>Polar Capital Fund<br>Global Convertible S Inc<br>Polar Capital Holdings<br>2 1/2p New Ordinary Shares<br>Porsche Automobile HLDGS SE<br>NPV Non Vtg Pref Shares<br>Princess Private Equity Hldgs<br>EUR0.001 Ordinary Shares<br>Procter & Gamble Co<br>NPV Common Stock<br>Rathbones Asset MGMT<br>High Quality Bond S Dist<br>Regional Reit Ltd<br>NPV Ordinary Shares<br>Relx Plc<br>14.44p Ordinary Shares<br>RHI Magnesita NV<br>EUR1.00 Ordinary Shares DI<br>Rio Tinto Plc<br>10p Ordinary Shares<br>Roche Holdings AG<br>Genusscheine NPV Shares<br>Rohm Co Ltd<br>NPV Shares<br>Rohto Pharmaceutical Co Ltd<br>NPV Shares<br>Sainsbury J Plc<br>28 4/7p Ordinary Shares<br>**Carried forward**||**A**|**t 1January 2023**||**Additions**|||**Disposals**||**At 31**|**Market Value**<br>**December 2023**<br>2,905,020<br>50,179<br>29,394<br> <br>-<br>61,489<br>43,264<br>28,605<br>35,646<br>19,814<br>401,463<br>31,407<br>86,724<br>40,533<br>20,566<br>40,947<br> <br>-<br>81,310<br> <br>-<br>43,800<br> <br>-<br> <br>-<br>65,584<br> <br>-<br> <br>-<br>21,222<br>19,245<br>94,998<br> <br>-<br>244,544<br>25,463<br>42,141<br> <br>-<br>80,620<br>39,650<br>39,698<br>20,565<br> <br>-<br>4,613,891|**Net Income**|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
||**Holding**<br>6,085,246<br>26,582<br>11,706<br>197<br>76,000<br>90,681<br>45<br>-<br>8,909<br>527,824<br>507<br>245<br>446<br>1,804<br>1,000<br>310,000<br>-<br>683<br>3,252<br>235<br>15,000<br>64,000<br>-<br>6,639<br>4,554<br>480<br>11,800<br>293<br>300,000<br>72,337<br>1,355<br>724<br>1,380<br>174<br>660<br>-<br>6,000<br>7,630,758|**Book Value**|**Market Value**|**Quantity**<br> <br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br>9,301<br> <br>-<br> <br>-<br> <br>72<br> <br>49<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br>1,242<br> <br>(621)<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br>1,500<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>1,980<br>1,300<br> <br>-|**Cost**|**Quantity**<br>**Proceeds**<br>610,765<br> <br>-<br>-<br> <br>-<br>-<br>197        63,634<br> <br>-<br>-<br> <br>-<br>-<br> <br>-<br>-<br>-<br>-<br> <br>-<br>-<br> <br>-<br>-<br>-<br>-<br>-<br>-<br> <br>-<br>-<br> <br>-<br>-<br> <br>-<br>-<br>310,000        22,958<br>240        17,790<br>62          8,173<br> <br>-<br>-<br>235        11,460<br>15,000        15,789<br> <br>-<br>-<br>1,500        12,546<br> <br>6,639        43,087<br> <br>-<br>-<br> <br>-<br>-<br> <br>1,233        10,305<br>293        33,137<br>30,500        27,017<br> <br>-<br>-<br> <br>-<br>-<br>724        20,286<br> <br>-<br>-<br> <br>-<br>-<br> <br>-<br>-<br>-<br>-<br> <br>6,000        16,534<br>913,481||**Profit/(Loss)**|**Holding**<br>26,582<br>11,706<br>-<br>76,000<br>90,681<br>45<br>9,301<br>8,909<br>527,824<br>579<br>294<br>446<br>1,804<br>1,000<br>-<br>1,002<br>-<br>3,252<br>-<br>-<br>64,000<br>-<br>-<br>4,554<br>480<br>10,567<br>-<br>269,500<br>72,337<br>1,355<br>-<br>1,380<br>174<br>2,640<br>1,300<br>-|**Book Value**|||
|||2,461,063<br>29,408<br>24,085<br>30,217<br>70,087<br>66,400<br>27,197<br>-<br>17,936<br>404,127<br>30,622<br>43,950<br>25,975<br>25,925<br>30,319<br>27,276<br>-<br>32,432<br>43,262<br>36,578<br>15,294<br>75,193<br>-<br>46,907<br>21,555<br>24,694<br>66,700<br>29,292<br>301,014<br>73,502<br>19,986<br>21,570<br>49,033<br>31,023<br>42,623<br>-<br>12,598|<br>3,141,265<br> <br>47,130<br> <br>29,206<br> <br>53,309<br> <br>56,733<br> <br>41,178<br> <br>27,145<br> <br>-<br> <br>16,736<br> <br>446,908<br> <br>27,669<br> <br>48,845<br> <br>42,937<br> <br>19,348<br> <br>34,855<br> <br>25,487<br> <br>-<br> <br>76,435<br> <br>17,356<br> <br>13,914<br> <br>15,395<br> <br>64,100<br> <br>-<br> <br>46,539<br> <br>21,723<br> <br>21,736<br> <br>88,361<br> <br>36,917<br> <br>261,900<br> <br>42,679<br> <br>31,002<br> <br>16,102<br> <br>80,012<br> <br>45,419<br> <br>39,629<br> <br>-<br> <br>13,062||328,808<br>-<br>-<br>-<br>-<br>-<br>-<br>39,097<br>-<br>-<br>4,477<br>9,398<br>-<br>-<br>-<br>-<br>29,488<br>(29,488)<br>-<br>-<br>-<br>-<br>16,829<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>23,837<br>-|||<br>44,600<br> <br>-<br> <br>-<br> <br>33,417<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>(4,318)<br> <br>12,092<br> <br>5,230<br> <br>-<br> <br>(25,118)<br> <br>495<br> <br>-<br> <br>(4,283)<br> <br>(3,820)<br> <br>-<br> <br>-<br> <br>3,336<br> <br>3,845<br> <br>(3,586)<br> <br>-<br> <br>-<br> <br>(1,284)<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>3,936||2,223,706<br> <br>29,408<br> <br>24,085<br> <br>-<br> <br>70,087<br> <br>66,400<br> <br>27,197<br> <br>39,097<br> <br>17,936<br> <br>404,127<br> <br>35,099<br> <br>53,348<br> <br>25,975<br> <br>25,925<br> <br>30,319<br> <br>-<br> <br>23,790<br> <br>-<br> <br>43,262<br> <br>-<br> <br>-<br> <br>75,193<br> <br>-<br> <br>-<br> <br>21,555<br> <br>24,694<br> <br>59,731<br> <br>-<br> <br>270,411<br> <br>73,502<br> <br>19,986<br> <br>-<br> <br>49,033<br> <br>31,023<br> <br>42,623<br> <br>23,837<br> <br>-||96,333<br>1,233<br>2,299<br>597<br>2,057<br>2,285<br>366<br>-<br>1,773<br>22,905<br>1,681<br>557<br>761<br>503<br>927<br>359<br>-<br>787<br>-<br>-<br>-<br>4,240<br>144<br>2,043<br>2,095<br>771<br>3,281<br>373<br>8,831<br>4,449<br>757<br>739<br>4,458<br>940<br>601<br>72<br>552|
|||4,257,843|4,991,032||422,445||913,481|64,542||3,831,348||169,769|





## **THE HAREBELL CENTENARY FUND** 

A   P   P   E   N   D   I   X   :       I   N   V   E   S   T   M   E   N   T       P   O   R   T   F   O   L   I   O 

## **Year ended 31 December 2023** 

|**Name**<br>**Security Type**<br>**Brought forward**<br>Sandfire Resources Ltd<br>NPV shares<br>Sandvik AB<br>NPV Shares<br>Sanwa Holdings Corp<br>NPV shares<br>Savills Plc<br>2 1/2p Ordinary Shares<br>Schneider Electric SE<br>EUR4 Shares<br>Sekisui Chemical Co<br>NPV Shares<br>Sensirion Holding AG<br>CHF0.1 Shares<br>Sequoia Economic Infrastructure<br>NPV Ordinary Shares<br>Seven & I Holdings Co Ltd<br>NPV shares<br>Severn Trent Plc<br>97.89p Ordinary Shares<br>Shell PLC<br>EUR0.07 Ord Shs UK Quote<br>Shin-Etsu Chemical Co<br>NPV Shares<br>Shoei Co Ltd<br>NPV Shares<br>Redcare Pharmacy NV<br>EUR0.02 Shares<br>Singapore Airlines<br>3.03% Snr EMTN<br>Snam Spa<br>NPV shares<br>Spirax-Sarco Engineering PLc<br>26.9230769p Ordinary Shares<br>Sociedad Quimica Y Minera ADR<br>Each Rep 1 Ser B Pref Shs<br>Sony Corp<br>NPV shares<br>Standard Chartered<br>USD0.50 Ordinary Shares<br>Sweden Kingdom of<br>1% Index Lkd Snr 1/06/2025<br>Swiss Re AG<br>CHF0.1 Shares<br>TAG Immobilien AG<br>NPV shares<br>Tharisa Plc<br>USD0.001 Ordinary Shares<br>Thermo Fisher Scientific Inc<br>USD1 Common Stock<br>Tokyo Electron Ltd<br>NPV Shares<br>Topcon Corporation<br>NPV shares<br>Treasury<br>0% T-Bill 22/01/2024<br>Treasury<br>1/2% Snr 22/10/2061<br>Treasury<br>1/4% Gilt 31/07/2031<br>Treasury<br>1/8% I/L Stock 22/03/2026<br>Treasury<br>4 1/4% Stock 7/03/2036<br>Treasury<br>7/8% Bonds 31/01/2046<br>Treasury<br>1/8% I/L Stock 22/03/2029<br>Treasury<br>1/8 % I/L Gilt 10/08/2028<br>**Carried forward**<br>18||**A**|**t 1January 2023**||**Additions**|||**Disposals**||**At 31**|**Market Value**<br>**December 2023**<br>4,613,891<br>41,351<br>39,810<br>30,104<br>44,574<br>49,145<br>27,142<br>40,808<br>152,613<br>21,792<br> <br>-<br>179,722<br>38,685<br>25,718<br>28,378<br>65,752<br>38,255<br>26,263<br>26,265<br>44,396<br>51,728<br>55,075<br>47,591<br>85,483<br>10,586<br> <br>-<br>50,588<br>26,641<br>269,228<br>20,385<br>32,781<br>42,292<br>36,143<br>28,532<br>38,558<br>43,870<br>6,374,145|**Net Income**|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
||**Holding**<br>7,630,758<br>-<br>2,345<br>2,530<br>4,600<br>263<br>1,950<br>443<br>178,704<br>-<br>862<br>6,989<br>235<br>1,156<br>250<br>110,000<br>9,484<br>-<br>556<br>595<br>7,760<br>-<br>540<br>7,423<br>16,286<br>82<br>-<br>3,150<br>-<br>-<br>-<br>-<br>-<br>-<br>24,000<br>32,000<br>8,042,961|**Book Value**|**Market Value**|**Quantity**<br> <br>10,525<br> <br>-<br> <br>-<br> <br>-<br> <br>49<br> <br>450<br> <br>82<br> <br>-<br>700<br> <br>-<br> <br>-<br> <br>940<br> <br>1,356<br> <br>-<br> <br>-<br> <br>-<br>250<br> <br>-<br> <br>-<br> <br>-<br>545,000<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br>360<br> <br>-<br>270,000<br>60,000<br>41,400<br>29,000<br>34,000<br>53,000<br> <br>-<br> <br>-|**Cost**|**Quantity**<br>**Proceeds**<br>913,481<br>-<br>-<br> <br>-<br>-<br> <br>-<br>-<br> <br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br> <br>-<br>-<br>-<br>-<br>862        23,061<br> <br>-<br>-<br> <br>-<br>-<br>-<br>-<br> <br>-<br>-<br> <br>-<br>-<br> <br>-<br>-<br>-<br>-<br> <br>-<br>-<br> <br>-<br>-<br> <br>-<br>-<br>-<br>-<br> <br>-<br>-<br> <br>-<br>-<br> <br>-<br>-<br>82        33,778<br>-<br>-<br> <br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br> <br>-<br>-<br> <br>-<br>-<br>970,321||**Profit/(Loss)**|**Holding**<br>10,525<br>2,345<br>2,530<br>4,600<br>312<br>2,400<br>525<br>178,704<br>700<br>-<br>6,989<br>1,175<br>2,512<br>250<br>110,000<br>9,484<br>250<br>556<br>595<br>7,760<br>545,000<br>540<br>7,423<br>16,286<br>-<br>360<br>3,150<br>270,000<br>60,000<br>41,400<br>29,000<br>34,000<br>53,000<br>24,000<br>32,000|**Book Value**|||
|||4,257,843<br>-<br>42,246<br>19,934<br>29,793<br>34,715<br>23,576<br>31,744<br>181,689<br>-<br>14,639<br>99,145<br>20,645<br>19,764<br>22,565<br>64,506<br>37,223<br>-<br>36,558<br>29,700<br>95,093<br>-<br>38,081<br>53,064<br>21,049<br>37,359<br>-<br>27,712<br>-<br>-<br>-<br>-<br>-<br>-<br>38,529<br>38,887|<br>4,991,032<br> <br>-<br> <br>35,249<br> <br>19,463<br> <br>37,973<br> <br>30,502<br> <br>22,668<br> <br>39,010<br> <br>156,902<br> <br>-<br> <br>22,852<br> <br>162,564<br> <br>24,023<br> <br>37,364<br> <br>9,910<br> <br>67,615<br> <br>38,093<br> <br>-<br> <br>36,903<br> <br>37,619<br> <br>48,298<br> <br>-<br> <br>41,962<br> <br>39,614<br> <br>15,960<br> <br>37,540<br> <br>-<br> <br>30,385<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>35,984<br> <br>40,758||422,445<br>36,707<br>-<br>-<br>-<br>6,823<br>5,291<br>5,524<br>-<br>25,953<br>-<br>-<br>-<br>3,127<br>-<br>-<br>-<br>22,811<br>-<br>-<br>-<br>53,238<br>-<br>-<br>-<br>-<br>42,431<br>-<br>269,022<br>17,782<br>30,597<br>41,114<br>33,981<br>26,680<br>-<br>-||913,481<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>23,061<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>33,778<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-|<br>64,542<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>8,422<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>(3,581)<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-||3,831,348<br> <br>36,707<br> <br>42,246<br> <br>19,934<br> <br>29,793<br> <br>41,538<br> <br>28,867<br> <br>37,268<br> <br>181,689<br> <br>25,953<br> <br>-<br> <br>99,145<br> <br>20,645<br> <br>22,891<br> <br>22,565<br> <br>64,506<br> <br>37,223<br> <br>22,811<br> <br>36,558<br> <br>29,700<br> <br>95,093<br> <br>53,238<br> <br>38,081<br> <br>53,064<br> <br>21,049<br> <br>-<br> <br>42,431<br> <br>27,712<br> <br>269,023<br> <br>17,782<br> <br>30,597<br> <br>41,114<br> <br>33,981<br> <br>26,680<br> <br>38,529<br> <br>38,887||169,769<br>-<br>634<br>715<br>1,651<br>537<br>648<br>-<br>12,286<br>178<br>921<br>6,956<br>564<br>770<br>-<br>2,006<br>1,667<br>-<br>1,865<br>223<br>1,254<br>-<br>1,774<br>-<br>924<br>36<br>184<br>624<br>-<br>-<br>52<br>26<br>361<br>140<br>46<br>53|
|||5,316,059|6,060,243||1,043,527||970,321|69,383||5,458,649||206,864|





## **THE HAREBELL CENTENARY FUND** 

A   P   P   E   N   D   I   X   :       I   N   V   E   S   T   M   E   N   T       P   O   R   T   F   O   L   I   O 

## **Year ended 31 December 2023** 

|**Name**<br>**Security Type**<br>**Brought forward**<br>Treasury<br>1/8% I/L Stock 22/03/2024<br>Treasury<br>0% T-Bill 11/04/2023<br>Treasury<br>0% T-Bill 24/04/2023<br>Treasury<br>0% T-Bill 17/04/2023<br>Treasury<br>0% T-Bill 5/06/2023<br>Treasury<br>0% T-Bill 11/09/2023<br>Treasury<br>0% T-Bill 4/12/2023<br>Treasury<br>0% T-bill 30/10/2023<br>Tritax Big Box REIT Plc<br>1p Ordinary Shares<br>Unilever Plc<br>3 1/9p Ordinary Shares<br>United Utilities Group Plc<br>5p Ordinary Shares<br>Vanguard Intl Equity<br>FTSE Emerging Markets Idx ETF<br>Vanguard Investments<br>S&P 500 UCITS ETF Inc GBP<br>Verisk Analytics Inc<br>USD0.001 Common Stock<br>Visa Inc<br>USD0.0001 Common Stock<br>Vodafone Group Plc<br>USD0.2095238 Ordinary Shares<br>Volkswagen AG<br>NPV Non Vtg Pref Shares<br>Wisdomtree Commodity Secs Ltd<br>Agriculture DJ-AIGCI<br>Wisdomtree Metal Secs Ltd<br>Daily Hgd Pysical Gold GBP<br>Woodside Energy Group Ltd<br>NPV Ordinary Shares<br>Zurich Finance IRE Plc<br>5.125% Flt Rt Gtd Sub 23/11/52<br>**Carried forward**||**A**|**t 1January 2023**||**Additions**|||**Disposals**||**At 31**|**Market Value**<br>**December 2023**<br>6,374,145<br>158,375<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br>43,012<br>70,680<br> <br>-<br>114,550<br>551,718<br> <br>-<br> <br>-<br>22,131<br> <br>-<br>92,755<br>121,000<br>25,544<br>58,078<br>7,631,989|**Net Income**|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
||**Holding**<br>8,042,961<br>102,500<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>25,466<br>1,860<br>3,835<br>1,911<br>337<br>253<br>230<br>32,280<br>231<br>8,323<br>11,183<br>1,536<br>60,000<br>8,292,906|**Book Value**|**Market Value**|**Quantity**<br> <br> <br>-<br>100,000<br>130,000<br>230,000<br>300,000<br>350,000<br>300,000<br>250,000<br> <br>-<br> <br>-<br> <br>-<br> <br>1,642<br> <br>7,445<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>10,017<br> <br>-<br> <br>-<br> <br>-|**Cost**|**Quantity**<br>**Proceeds**<br>970,321<br> <br>-<br>-<br>100,000      100,000<br>130,000      130,000<br>230,000      230,000<br>300,000      300,000<br>350,000      350,000<br>300,000      300,000<br>250,000      250,000<br> <br>-<br>-<br> <br>-<br>-<br> <br>3,835        40,724<br>-<br>-<br>-<br>-<br>253        49,736<br>230        44,202<br> <br>-<br>-<br>231        24,107<br>-<br>-<br> <br>-<br>-<br> <br>-<br>-<br> <br>-<br>-<br>2,789,091||**Profit/(Loss)**|**Holding**<br>102,500<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>25,466<br>1,860<br>-<br>3,553<br>7,782<br>-<br>-<br>32,280<br>-<br>18,340<br>11,183<br>1,536<br>60,000|**Book Value**|||
|||5,316,059<br>123,018<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>28,308<br>28,364<br>33,524<br>62,729<br>15,183<br>35,674<br>36,506<br>73,568<br>32,341<br>47,538<br>97,401<br>28,571<br>54,967|<br>6,060,243<br> <br>153,034<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>35,296<br> <br>77,785<br> <br>38,020<br> <br>61,926<br> <br>20,380<br> <br>37,106<br> <br>39,725<br> <br>27,193<br> <br>23,848<br> <br>46,526<br> <br>108,279<br> <br>30,566<br> <br>54,874||1,043,527<br>-<br>99,687<br>129,600<br>227,870<br>299,058<br>345,870<br>298,797<br>249,001<br>-<br>-<br>-<br>56,013<br>490,129<br>-<br>-<br>-<br>-<br>53,717<br>-<br>-<br>-|||<br>69,383<br> <br>-<br> <br>313<br> <br>400<br> <br>2,130<br> <br>942<br> <br>4,130<br> <br>1,203<br> <br>999<br> <br>-<br> <br>-<br> <br>7,200<br> <br>-<br> <br>-<br> <br>14,062<br> <br>7,696<br> <br>-<br> <br>(8,234)<br> <br>-<br> <br>-<br> <br>-<br> <br>-||5,458,649<br> <br>123,018<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>-<br> <br>28,308<br> <br>28,364<br> <br>-<br> <br>118,742<br> <br>505,313<br> <br>-<br> <br>-<br> <br>73,568<br> <br>-<br> <br>101,255<br> <br>97,401<br> <br>28,571<br> <br>54,967||206,864<br>194<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>1,840<br>2,792<br>1,745<br>3,368<br>1,593<br>231<br>212<br>2,525<br>4,113<br>-<br>-<br>2,832<br>3,076|
|||6,013,751|6,814,801||3,293,267||2,789,091|100,224||6,618,155||231,385|



